VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from t...
2026-07-06T13:15:07.000Z - 13 hours ago
Jul 6, 2026, 7:00 AM EDT - 15 hours ago
2026-07-02T11:30:29.000Z - 4 days ago
Jul 2, 2026, 7:00 AM EDT - 4 days ago
2026-06-24T11:10:26.000Z - 12 days ago
Jun 24, 2026, 7:00 AM EDT - 12 days ago
2026-06-18T11:21:38.000Z - 18 days ago
Jun 18, 2026, 7:00 AM EDT - 18 days ago
2026-06-16T15:10:31.000Z - 20 days ago
2026-06-16T15:00:10.000Z - 20 days ago